Peripheral artery disease (PAD) affects over 113 million people worldwide and is a marker of systemic atherosclerosis ...
• At a median follow-up of 2.9 years, primary endpoint events occurred in 33.7% of the IVUS-guided group and 30.9% in the ...
GLP-1 receptor agonists reduced atherosclerosis progression in rabbits, and were associated with significantly lower levels ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results